Shingrix Effectiveness in Preventing Shingles in Seniors
A real-world analysis reveals that Shingrix is highly effective in preventing shingles in adults over 65, including those with compromised immune systems.
According to a study published in Annals of Internal Medicine, two doses of Shingrix provide better protection against shingles than a single dose.
What is Shingles?
Shingles is a viral infection caused by the reactivation of the varicella-zoster virus (VZV), which is the same virus responsible for chickenpox. It commonly presents as a rash with painful blisters across the chest, abdomen, or face.
Risk and Complications
While anyone can contract shingles, it is more common in adults over 50, as stated by the CDC. A significant complication of shingles is post-herpetic neuralgia (PHN), a long-lasting nerve pain that affects 5% to 30% of patients and can persist for weeks or months.
Shingrix, a recombinant zoster vaccine (RZV) manufactured by GSK, has been shown to be effective in preventing shingles in seniors.
No direct quote available in the provided text.
Author's summary: Shingrix is highly effective in preventing shingles in seniors.